PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trialZehua Wu, Yanhong Deng, Fangqian Li et al.|Med|2024Cited by 16
Abstract 5433: XRCC5 promotes tumor growth and progression via PDK-1 signaling and predicts poor prognosis in melanomaGe Qin, Wuguo Deng, Tianze Liu et al.|Cancer Research|2018Cited by 0